Post by Croda

We are pleased to announce that Avanti Research, has entered into a collaboration with NovoArc GmbH to broaden access to innovative lipid technologies. This collaboration strengthens our ability to support customers developing next-generation therapies by extending our portfolio with differentiated lipid systems designed to enhance stability and enable more flexible formulation approaches. These technologies offer potential to explore alternative delivery routes for complex therapeutics alongside traditional methods. By combining NovoArc’s innovation with Croda’s global capabilities and established platform, we are enabling researchers to more easily investigate new approaches to delivering mRNA, protein and peptide-based therapies, supporting progress from early-stage research through to future scale-up. This agreement also reflects our continued focus on growing a differentiated portfolio of high-value pharmaceutical technologies and reinforcing our position as a partner of choice in the development of advanced therapeutics. Read more about this partnership: https://ow.ly/jyfL50ZbOLS #CrodaPharma #AvantiResearch #DrugDelivery #Biologics #mRNA #SmartScience